Zoloft and Coronary artery occlusion - a phase IV clinical study of FDA data

Summary:

Coronary artery occlusion is found among people who take Zoloft, especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Zoloft and have Coronary artery occlusion. It is created by eHealthMe based on reports of 118,546 people who have side effects when taking Zoloft from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

118,546 people reported to have side effects when taking Zoloft.
Among them, 290 people (0.24%) have Coronary artery occlusion.


What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 128,418 Zoloft users for its effectiveness, alternative drugs and more.

What is Coronary artery occlusion?

Coronary artery occlusion (complete obstruction of blood flow in a coronary artery) is found to be associated with 1,533 drugs and 974 conditions by eHealthMe.

Number of Zoloft and Coronary artery occlusion reports submitted per year:

Could Zoloft cause Coronary artery occlusion?

Time on Zoloft when people have Coronary artery occlusion *:

Click here to view

Gender of people who have Coronary artery occlusion when taking Zoloft*:

Click here to view

Age of people who have Coronary artery occlusion when taking Zoloft *:

Click here to view

Common drugs people take besides Zoloft *:

Click here to view

Common side effects people have besides Coronary artery occlusion *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Coronary artery occlusion?

Check whether Coronary artery occlusion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Zoloft:

Coronary artery occlusion treatments and more:

COVID vaccines that are related to Coronary artery occlusion:

How severe was Coronary artery occlusion and when was it recovered:

Expand to all the drugs that have ingredients of sertraline hydrochloride:

Common drugs associated with Coronary artery occlusion:

All the drugs that are associated with Coronary artery occlusion:

Common conditions associated with Coronary artery occlusion:

All the conditions that are associated with Coronary artery occlusion:

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: